As discussed before, previously E-selectin negative tumor-associated vessels in human SCC samples up-regulated E-selectin following treatment with imiquimod (TLR-7 agonist) which resulted in CD8+ T cell influx into the tumor and tumor regression (129). Here, TLR7 is linked to neoplasm.